Explore more topics
SEC Form 4 research

INTERCEPT PHARMACEUTICALS, INC. insider transactions

Inspect INTERCEPT PHARMACEUTICALS, INC.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001270073
Reporting owners
42
Officers and directors
24
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 27 rows, 3 columns

Scroll sideways to compare all columns. Select a heading to sort.

Campagna Jason00017933383
Kapadia Sandip000167714115
Pruzanski Mark000155956989
Ford David A00017052954
Fundaro Paolo000155953722
McMinn Rachel000160630218
Cawkwell Gail00017611672
Adorini Luciano000155951264
AKKARAJU SRINIVAS0001253170203
Benatti Luca00016138423
BRADBURY DANIEL0001236397676
DUNCAN BARBARA GAYLE000135312853
Gottesdiener Keith Michael000161585616
ISALY SAMUEL D0001055949417
Kim Richard J00017051543
Morrison Lisa000163511137
ORBIMED ADVISORS LLC00010559511,020
OrbiMed Capital GP IV LLC0001502240195
Regan Daniel Paul000157132047
Shapiro David0001559570171
SILVERSTEIN JONATHAN0001171005123
Sullivan Ryan T000157882312
TALLARIGO LORENZO000127603921
VEITINGER KLAUS R DR0001283972115
WELCH DANIEL G000120619982
Weyer Christian000149381117
WILLIAMS NICOLE000118900614

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.